Skip to main content
NCBI home page
Netherlands Heart Journal logoLink to Netherlands Heart Journal
editorial
. 2001 Nov;9(8):315–317.

Percutaneous septal ablation: a new treatment for hypertrophic obstructive cardiomyopathy

H Seggewiss
PMCID: PMC2499647  PMID: 25696752

Full text

PDF
315

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Faber L., Seggewiss H., Gleichmann U. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography. Circulation. 1998 Dec 1;98(22):2415–2421. doi: 10.1161/01.cir.98.22.2415. [DOI] [PubMed] [Google Scholar]
  2. Faber L., Seggewiss H., Ziemssen P., Gleichmann U. Intraprocedural myocardial contrast echocardiography as a routine procedure in percutaneous transluminal septal myocardial ablation: detection of threatening myocardial necrosis distant from the septal target area. Catheter Cardiovasc Interv. 1999 Aug;47(4):462–466. doi: 10.1002/(SICI)1522-726X(199908)47:4<462::AID-CCD16>3.0.CO;2-9. [DOI] [PubMed] [Google Scholar]
  3. Knight C., Kurbaan A. S., Seggewiss H., Henein M., Gunning M., Harrington D., Fassbender D., Gleichmann U., Sigwart U. Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients. Circulation. 1997 Apr 15;95(8):2075–2081. doi: 10.1161/01.cir.95.8.2075. [DOI] [PubMed] [Google Scholar]
  4. Maron B. J., Casey S. A., Poliac L. C., Gohman T. E., Almquist A. K., Aeppli D. M. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. JAMA. 1999 Feb 17;281(7):650–655. doi: 10.1001/jama.281.7.650. [DOI] [PubMed] [Google Scholar]
  5. Nagueh S. F., Lakkis N. M., He Z. X., Middleton K. J., Killip D., Zoghbi W. A., Quiñones M. A., Roberts R., Verani M. S., Kleiman N. S. Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 1998 Jul;32(1):225–229. doi: 10.1016/s0735-1097(98)00220-4. [DOI] [PubMed] [Google Scholar]
  6. Seggewiss H., Faber L., Gleichmann U. Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy. Thorac Cardiovasc Surg. 1999 Apr;47(2):94–100. doi: 10.1055/s-2007-1013118. [DOI] [PubMed] [Google Scholar]
  7. Seggewiss H., Faber L. Percutaneous septal ablation for hypertrophic cardiomyopathy and mid-ventricular obstruction. Eur J Echocardiogr. 2000 Dec;1(4):277–280. doi: 10.1053/euje.2000.0032. [DOI] [PubMed] [Google Scholar]
  8. Seggewiss H., Gleichmann U., Faber L., Fassbender D., Schmidt H. K., Strick S. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients. J Am Coll Cardiol. 1998 Feb;31(2):252–258. doi: 10.1016/s0735-1097(97)00508-1. [DOI] [PubMed] [Google Scholar]
  9. Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet. 1995 Jul 22;346(8969):211–214. doi: 10.1016/s0140-6736(95)91267-3. [DOI] [PubMed] [Google Scholar]
  10. Spirito P., Seidman C. E., McKenna W. J., Maron B. J. The management of hypertrophic cardiomyopathy. N Engl J Med. 1997 Mar 13;336(11):775–785. doi: 10.1056/NEJM199703133361107. [DOI] [PubMed] [Google Scholar]

Articles from Netherlands Heart Journal are provided here courtesy of Springer

RESOURCES